Dolphin Medical Services Ltd.

BSE: DOLPHMED526504ISIN INE796B01013

Healthcare
Healthcare Service Provider

Share price

₹6.61+0.31 (+4.92%)

as of 28 Sep 2026

52W high: ₹9.57
52W low: ₹1.98
Off 52W high: -30.93%
1M return: -5.30%
3M return: -27.52%
6M return: +35.45%
1Y return: +192.48%
20D avg volume: 1,79,943
50 DMA: ₹5.16
200 DMA: —

Key ratios Standalone

Market cap: ₹9.98 Cr
Current price: ₹6.61
52W high / low: ₹9.57 / ₹1.98
Face value: ₹10.00
P/E: 220.33
P/B: 0.98
EPS (TTM): ₹0.03
Book value / share: ₹6.74
ROE: 0.47%
ROCE: 0.60%
Operating margin: 19.90%
Net margin: 8.74%
Debt / equity: 0.09
Net debt: ₹0.86 Cr
Interest cover: 7.00
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 4.9 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	0.21	0.19	0.21	0.18	0.17	0.14	—
	0.01	0.01	0.01	0.01	0.01	0.01	—
	0.20	0.19	0.20	0.19	0.15	0.22	—
	0.04	0.02	0.03	0.03	0.02	0.05	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.05	0.03	0.05	0.04	0.03	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.02	0.02	0.03	0.03	0.01	0.03	—
	0.09	0.11	0.09	0.09	0.08	0.13	—
	0.02	0.01	0.02	0.01	0.03	-0.07	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.02	0.01	0.02	0.01	0.03	-0.07	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.02	0.01	0.02	0.01	0.03	-0.07	—
	0.11	0.01	0.01	0.00	0.02	-0.05	—
Key metrics
	0.04	0.03	0.05	0.04	0.04	-0.04	—
	19.00%	15.80%	23.80%	22.20%	23.50%	-28.60%	—
	9.50%	5.30%	9.50%	5.60%	17.60%	-50.00%	—
	—	0.10%	—	0.10%	—	-0.60%	—
	23.50%	35.70%	—	—	—	—	—
	-33.30%	114.30%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.79	0.75	0.78	—
	0.04	0.04	0.04	—
	0.78	0.73	0.85	—
	0.12	0.10	0.12	—
	0.00	0.00	0.00	—
	0.17	0.15	0.07	—
	0.00	0.01	0.01	—
	0.10	0.09	0.06	—
	0.38	0.37	0.59	—
	0.06	0.06	-0.03	—
	0.00	0.00	0.00	—
	0.06	0.06	-0.03	—
	0.00	0.02	0.00	—
	0.06	0.04	-0.03	—
	0.13	0.04	-0.02	—
Key metrics
	0.16	0.16	0.04	—
	20.25%	21.30%	5.10%	—
	7.59%	5.30%	-3.80%	—
	—	0.60%	-0.20%	—
	—	-3.80%	—	—
	—	233.30%	—	—
	—	-0.31	-0.06	—
	—	3.50	2.00	—
	—	0.09	0.09	—
	—	0.86	0.85	—
	—	4.9	4.7	—
Balance sheet
	—	12.43	12.08	—
	—	1.97	1.98	—
	—	0.01	0.02	—
	—	0.00	0.00	—
	—	0.01	0.01	—
	—	3.13	2.76	—
	—	0.00	0.00	—
	—	0.00	0.58	—
	—	0.87	0.87	—
	—	0.00	0.00	—
	—	0.87	0.87	—
	—	10.08	10.04	—
Cash flow
	—	0.14	-0.06	—
	—	-0.45	0.00	—
	—	0.31	0.06	—
	—	0.45	0.00	—

Compounded growth

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY (TTM)	Profit YoY (TTM)	1Y return
Dr. Lal Pathlabs Limited	32,590	1,941.60	59.58	25.70%	+14.29%	+5.38%	-39.24%
Vijaya Diagnostic Centre Limited	15,447	1,499.75	83.17	19.20%	+20.18%	+24.26%	+47.31%
Metropolis Healthcare Limited	11,867	572.20	59.47	15.70%	—	—	-71.56%
Thyrocare Technologies Limited	8,735	548.80	49.66	33.60%	+21.09%	+67.13%	-51.07%
Nephrocare Health Services Limited	6,780	674.20	—	13.70%	—	—	—
SURAKSHA DIAGNOSTIC LIMITED	1,810	347.45	51.59	14.70%	—	—	+16.55%
Krsnaa Diagnostics Limited	1,737	535.55	17.83	10.60%	—	—	-32.29%
3B BlackBio Dx Limited	1,357	1,580.90	24.12	22.60%	—	—	+15.90%
ONE GLOBAL SERVICE PROVIDER LIMITED S	1,063	543.95	14.38	65.70%	—	—	+97.80%
HEALTH X PLATFORM LIMITED	891	280.15	-34.21	—	—	—	-10.32%
Gaudium IVF and Women Health Limited	816	112.05	—	23.10%	—	—	—
Aspira Pathlab & Diagnostics Limited	141	136.52	—	15.70%	—	—	+131.43%
STAR IMAGING AND PATH LAB LIMITED	134	77.00	—	22.60%	—	—	-43.09%
Choksi Laboratories Ltd. S	130	187.30	60.42	12.30%	—	—	-1.37%
MODERN DIAGNOSTIC & RESEARCH CENTRE LIMITED S	106	70.01	50.73	11.20%	—	—	—
BANDARAM PHARMA PACKTECH LIMITED	38	21.33	31.97	4.70%	—	—	-31.37%
N.G.Industries Ltd. S	35	105.35	18.32	6.30%	—	—	-29.77%
Sharma East India Hospitals And Res S	33	84.70	23.46	14.20%	—	—	-48.02%
Chennai Meenakshi Multispeciality Hospital Ltd. S	29	39.05	-71.00	-2.80%	—	—	-11.55%
Deccan Health Care Limited	28	11.71	10.79	3.20%	—	—	-40.26%
SAMSRITA LABS LIMITED	27	11.80	-3.29	-73.40%	—	—	-38.03%
Tejnaksh Healthcare Limited	27	13.19	21.78	5.90%	—	—	-27.49%
Transgene Biotek Ltd.	18	2.67	-12.58	-0.50%	—	—	-33.58%
Dhanvantri Jeevan Rekha Ltd. S	11	26.00	18.57	3.40%	—	—	-12.63%
Dolphin Medical Services Ltd. S	10	6.61	220.33	0.60%	—	—	+192.48%

Filings & corporate actions

Recent announcements

BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters21 Sep 2026 · Company Update / Change in Management
BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters21 Sep 2026 · Company Update / Change in Management Control
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to consider and approve To consider and approve ....20 Sep 2026 · Board Meeting / Board Meeting
Intimation of Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.12 Sep 2026 · Others / Outcome without intimation
Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA12 Sep 2026 · Company Update / Change in Management
Intimation of Extension of AGM3 Sep 2026 · Company Update / General
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board ....28 Aug 2026 · Company Update / General
Results14 Aug 2026 · Result / Financial Results
Board meeting outcome14 Aug 2026 · Board Meeting / Outcome of Board Meeting
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....9 Aug 2026 · Board Meeting / Board Meeting
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement ....30 Jul 2026 · Company Update / Open Offer
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (''IDC'') of Dolphin Medical Services ....29 Jul 2026 · Company Update / General
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").27 Jul 2026 · Company Update / General
Ms. Vaishnavi Sharma, Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.25 Jul 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.25 Jul 2026 · Company Update / Resignation of Company Secretary / Compliance Officer
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has informed BSE regarding the identified date for the purpose of determining the names of the shareholders to whom the Letter ....16 Jul 2026 · Company Update / Open Offer
certificate under Reg 74(5) from RTA3 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Dolphin Medical Services Ltd ("Target Company").1 Jun 2026 · Company Update / General
Annual Compliance Report under Regulation 24A of SEBI (LODR) for financial year ended 31 march, 2026.30 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Rarever Financial Advisors Pvt. Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of ....23 May 2026 · Company Update / General
Rarever Financial Advisors Private Limited (hereafter referred to as 'Manager to the Offer'), are hereby submitting the Detailed Public Statement made by us on behalf of Mr. Amarandhar ....23 May 2026 · Company Update / Open Offer - Updates
Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Detailed Public Statement in terms of Regulation 4 read with Regulations 13(4), 14(3) and 15(2) ....23 May 2026 · Company Update / General
Regulation 74(5)20 May 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Results16 May 2026 · Result / Financial Results
Board Meeting outcome16 May 2026 · Board Meeting / Outcome of Board Meeting
Rarever Financial Advisors Private Limited (hereafter referred to as "Manager to the Offer") are herby submitting the Public Announcement made by us on behalf of Mr Amarandhar Reddy Kotha ....15 May 2026 · Company Update / Open Offer
Open Offer - Public Announcement15 May 2026 · Company Update / Public Announcement-Open Offer
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2026 ,inter alia, to consider and approve Board meeting intimation11 May 2026 · Board Meeting / Board Meeting
Board meeting outcome22 Apr 2026 · Company Update / Change in Management
Board meeting outcome22 Apr 2026 · Board Meeting / Outcome of Board Meeting
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/04/2026 ,inter alia, to consider and approve Board meeting intimation19 Apr 2026 · Board Meeting / Board Meeting
Corrigendum to the Board meeting outcome30 Mar 2026 · Company Update / General
Closure of Trading window30 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Board meeting outcome12 Feb 2026 · Board Meeting / Outcome of Board Meeting
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 ,inter alia, to consider and approve Board meeting intimation10 Feb 2026 · Board Meeting / Board Meeting
Results6 Feb 2026 · Result / Financial Results
Standalone Unaudited Financial Results For The Quarter Ended December 31, 20256 Feb 2026 · Others / Outcome without intimation
Intimation of Deferment of Board Meeting31 Jan 2026 · Board Meeting / Outcome of Board Meeting
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2026 ,inter alia, to consider and approve Board meeting intimation16 Jan 2026 · Board Meeting / Board Meeting
Reg 74(5)15 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Board meetings

14 Aug 2026 Board Meeting - Financial Results